Literature DB >> 8185169

The cholecystokinin hypothesis of anxiety and panic disorder.

J Bradwejn1, D Koszycki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8185169     DOI： 10.1111/j.1749-6632.1994.tb44075.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  14 in total

1.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

2.  Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.

Authors:  Shouping Wang; An-Ping Zhang; Lalitha Kurada; Toshimitsu Matsui; Saobo Lei
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

3.  Chronic nicotine treatment impacts the regulation of opioid and non-opioid peptides in the rat dorsal striatum.

Authors:  Filomena Petruzziello; Sara Falasca; Per E Andren; Gregor Rainer; Xiaozhe Zhang
Journal:  Mol Cell Proteomics       Date:  2013-02-22       Impact factor: 5.911

Review 4.  Panic disorder.

Authors:  M H Rapaport; C Barrett
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

5.  Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.

Authors:  N Coupland; L Zedkova; G Sanghera; M Leyton; J M Le Mellédo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

6.  Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.

Authors:  J Shlik; A Aluoja; V Vasar; E Vasar; T Podar; J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

Review 7.  Cholecystokinin hyperresponsiveness in functional dyspepsia.

Authors:  A S B Chua; P W N Keeling
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

8.  Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.

Authors:  Qian Chen; Akira Nakajima; Corbin Meacham; Ya-Ping Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

9.  Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.

Authors:  Daniela Eser; Gregor Leicht; Jürgen Lutz; Stephan Wenninger; Valerie Kirsch; Cornelius Schüle; Susanne Karch; Thomas Baghai; Oliver Pogarell; Christine Born; Rainer Rupprecht; Christoph Mulert
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

10.  Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

Authors:  Innar Tõru; Jakov Shlik; Eduard Maron; Veiko Vasar; David J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.